Show simple item record

dc.contributor.authorJacobsen, Elisabet
dc.contributor.authorSawhney, Simon
dc.contributor.authorBrazzelli, Miriam
dc.contributor.authorAucott, Lorna
dc.contributor.authorScotland, Graham
dc.contributor.authorAceves Martins, Magaly
dc.contributor.authorRobertson, C
dc.contributor.authorImamura, Mari
dc.contributor.authorPoobalan, Amudha
dc.contributor.authorManson, Paul
dc.contributor.authorKaye, Callum
dc.contributor.authorBoyers, Dwayne
dc.date.accessioned2021-12-03T11:00:01Z
dc.date.available2021-12-03T11:00:01Z
dc.date.issued2021-12-01
dc.identifier.citationJacobsen , E , Sawhney , S , Brazzelli , M , Aucott , L , Scotland , G , Aceves Martins , M , Robertson , C , Imamura , M , Poobalan , A , Manson , P , Kaye , C & Boyers , D 2021 , ' Cost-effectiveness and value of information analysis of NephroCheck and NGAL tests compared to standard care for the diagnosis of acute kidney injury ' , BMC Nephrology , vol. 22 , 399 . https://doi.org/10.1186/s12882-021-02610-9en
dc.identifier.issn1471-2369
dc.identifier.otherPURE: 208438772
dc.identifier.otherPURE UUID: 8d350886-7aa8-4b78-b882-ce1beb57c7ce
dc.identifier.otherWOS: 000724754000001
dc.identifier.otherORCID: /0000-0002-6975-3874/work/104426109
dc.identifier.otherORCID: /0000-0002-7960-4573/work/104426322
dc.identifier.otherORCID: /0000-0002-9441-142X/work/104426454
dc.identifier.otherORCID: /0000-0001-6277-7972/work/104426471
dc.identifier.otherScopus: 85120743233
dc.identifier.urihttps://hdl.handle.net/2164/17616
dc.descriptionAcknowledgements We are grateful to Thomas Walker and Rebecca Albrow at NICE for their thoughtful comments on earlier versions of the economic model and to the NICE Diagnostic Committee for their critical review of our identifed evidence. We are also grateful for the advice and clinical guidance received from the NICE Specialist Advisory Group for DG19 and to Peter S Hall and Alison F Smith (on behalf of the team) for providing early versions of their economic model that was instrumental in the development and structuring of the model used in this study. A big thank goes also to Lara Kemp for her secretarial support and patience throughout the study. The results presented in this paper have not been published previously in any academic journals, nor have they been submitted elsewhere. This work has informed the development of NICE guidance for diagnostic testing for AKI (https://www.nice.org.uk/guidance/dg39) and a full report to the funder describing the totality of this work will be published in the NIHR, HTA mono‑ graph series in due course. Funding The fndings presented in this manuscript are part of a broader research project funded by the National Institute for Health Research (NIHR) and com‑missioned through the NICE Diagnostic Assessment Programme (project no 12/88/97). The views expressed are those of the authors and not necessarily those of NICE, the NHS, the NIHR or the Department of Health. The Health Economics Research Unit and the Health Services Research Unit, University of Aberdeen, are funded by the Chief Scientist Ofce of the Scottish Government Health and Social Care Directorates.en
dc.format.extent10
dc.language.isoeng
dc.relation.ispartofBMC Nephrologyen
dc.rights© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectAcute kidney injuryen
dc.subjectCritical careen
dc.subjectCost-effectivenessen
dc.subjectdiagnostic accuracyen
dc.subjectEconomic evaluationen
dc.subjectMarkov modelen
dc.subjectnephrologyen
dc.subjectR Medicineen
dc.subjectRA0421 Public health. Hygiene. Preventive Medicineen
dc.subjectNational Institute for Health Research (NIHR)en
dc.subject12/88/97en
dc.subjectSupplementary Informationen
dc.subjecthttps://doi. org/10.1186/s12882‐021‐02610‐9.en
dc.subject.lccRen
dc.subject.lccRA0421en
dc.titleCost-effectiveness and value of information analysis of NephroCheck and NGAL tests compared to standard care for the diagnosis of acute kidney injuryen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Health Economics Research Uniten
dc.contributor.institutionUniversity of Aberdeen.Centre for Health Data Scienceen
dc.contributor.institutionUniversity of Aberdeen.Data Safe Havenen
dc.contributor.institutionUniversity of Aberdeen.Farr Aberdeenen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Health Services Research Uniten
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Rowett Instituteen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1186/s12882-021-02610-9
dc.identifier.vol22en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record